Correlation Between Premier Biomedical and Integrated Cannabis

Can any of the company-specific risk be diversified away by investing in both Premier Biomedical and Integrated Cannabis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Premier Biomedical and Integrated Cannabis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Premier Biomedical and Integrated Cannabis Solutions, you can compare the effects of market volatilities on Premier Biomedical and Integrated Cannabis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Premier Biomedical with a short position of Integrated Cannabis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Premier Biomedical and Integrated Cannabis.

Diversification Opportunities for Premier Biomedical and Integrated Cannabis

-0.34

Correlation Coefficient

Premier Biomedical  Integrated Cannabis

Very good diversification

The 3 months correlation between Premier and Integrated is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Premier Biomedical and Integrated Cannabis Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Cannabis and Premier Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Premier Biomedical are associated (or correlated) with Integrated Cannabis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Cannabis has no effect on the direction of Premier Biomedical i.e., Premier Biomedical and Integrated Cannabis go up and down completely randomly.

Pair Corralation between Premier Biomedical and Integrated Cannabis

Given the investment horizon of 90 days Premier Biomedical is expected to generate 2.85 times less return on investment than Integrated Cannabis. In addition to that, Premier Biomedical is 1.84 times more volatile than Integrated Cannabis Solutions. It trades about 0.03 of its total potential returns per unit of risk. Integrated Cannabis Solutions is currently generating about 0.14 per unit of volatility. If you would invest  0.38  in Integrated Cannabis Solutions on December 30, 2024 and sell it today you would earn a total of  0.24  from holding Integrated Cannabis Solutions or generate 63.16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Premier Biomedical  vs.  Integrated Cannabis Solutions

Premier Biomedical

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Premier Biomedical are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady technical and fundamental indicators, Premier Biomedical demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Integrated Cannabis

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Integrated Cannabis Solutions are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile basic indicators, Integrated Cannabis disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Premier Biomedical and Integrated Cannabis

The main advantage of trading using opposite Premier Biomedical and Integrated Cannabis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Premier Biomedical position performs unexpectedly, Integrated Cannabis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Cannabis will offset losses from the drop in Integrated Cannabis' long position.

The idea behind Premier Biomedical and Integrated Cannabis Solutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.